Imagia Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 73
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $7M
Latest Deal Amount
  • Investors
  • 11

Imagia General Information

Description

Developer of a clinical intelligence platform designed to detect and quantify cancer changes and improve the health of cancer patients. The company's platform leverages advances in artificial intelligence to provide outcome-based structured clinical data and federated learning capabilities across multiple sources while preserving privacy, thereby enabling clinicians to drive end-to-end discoveries of predictive, diagnostic, and prescriptive analytics.

Contact Information

Website
www.imagia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Decision/Risk Analysis
Primary Office
  • 6650 Saint-Urbain Street
  • Suite 100
  • Montreal, Quebec H2S 3G9
  • Canada
+1 (855) 000-0000

Imagia Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Imagia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 02-Mar-2021 $7M 000.00 Completed Generating Revenue
6. Later Stage VC (Series B) 01-Sep-2019 000.00 000.00 Completed Generating Revenue
5. Grant 05-Dec-2018 000 000.00 Completed Generating Revenue
4. Grant 26-Mar-2018 000 000.00 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Nov-2017 000 000.00 Completed Startup
2. Early Stage VC (Series A) 01-Dec-2016 $5.5M $11.2M Completed Startup
1. Seed Round $5.7M $5.7M Completed Startup
To view Imagia’s complete valuation and funding history, request access »

Imagia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a clinical intelligence platform designed to detect and quantify cancer changes and improve the health of c
Other Healthcare Technology Systems
Montreal, Canada
73 As of 2022
000.00
0000000000 0 000.00

000000 0

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepte
0000000000000 00000000
Chicago, IL
0000 As of 0000
00.000
00000000

000000 0

sse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
00000 0000000000 0000000000 0000000
Saint Sulpice, Switzerland
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Imagia Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tempus Labs Venture Capital-Backed Chicago, IL 0000 00.000 00000000
000000 00000000 Formerly VC-backed Saint Sulpice, Switzerland 000 00000 000000000 00000
00000 Venture Capital-Backed Paris, France 000 00000 00000000000 00000
000000000 Venture Capital-Backed Boston, MA 000 00000 00000000000 00000
To view Imagia’s complete competitors history, request access »

Imagia Patents

Imagia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210232705-A1 Method and system for generating synthetically anonymized data for a given task Pending 13-Jul-2018 00000000000
CA-3105533-A1 Method and system for generating synthetically anonymized data for a given task Pending 13-Jul-2018 00000000000
EP-3821361-A1 Method and system for generating synthetically anonymized data for a given task Pending 13-Jul-2018 00000000000
EP-3430525-A1 Method and system for processing a task with robustness to missing input information Pending 17-Mar-2016 0000000000
CA-3017697-C Method and system for processing a task with robustness to missing input information Active 17-Mar-2016 G06K9/6256
To view Imagia’s complete patent history, request access »

Imagia Executive Team (6)

Name Title Board Seat Contact Info
Geralyn Ochab Chief Executive Officer
Alexandre Le Bouthillier Ph.D Co-Founder, Chief Corporate Officer, President and Treasurer
Anne-Marie Guertin Chief Financial Officer
Florent Chandelier Ph.D Chief Technology Officer
Nicolas Chapados Ph.D Co-Founder & Chief AI Scientist
You’re viewing 5 of 6 executive team members. Get the full list »

Imagia Board Members (4)

Name Representing Role Since
Feisal Keshavjee Imagia Board Member 000 0000
Jean-François Pariseau BDC Capital Chairman 000 0000
Jean-Marc Rousseau Imagia Board Member 000 0000
Jennifer Buechel Self Board Member 000 0000
To view Imagia’s complete board members history, request access »

Imagia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Imagia Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amplitude Ventures Venture Capital Minority 000 0000 000000 0
Investissement Québec Venture Capital Minority 000 0000 000000 0
Desjardins Capital Corporate Venture Capital Minority 000 0000 000000 0
PME MTL Centre-Ville Not-For-Profit Venture Capital Minority 000 0000 000000 0
Canada Economic Development for Quebec Regions Government 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Imagia Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 15-Nov-2017 0000000000 Decision/Risk Analysis 00é0é000
ai4gi 01-Jan-2003 Joint Venture Other Healthcare Services
To view Imagia’s complete investments and acquisitions history, request access »